UMIP PREMIER FUND: LOGO
UMIP PREMIER FUND: Home UMIP PREMIER FUND: Fund UMIP PREMIER FUND: The Team UMIP PREMIER FUND: Portfolio UMIP PREMIER FUND: News & Events UMIP PREMIER FUND: Submit a business plan UMIP PREMIER FUND: Contact us
 

Latest News:

... Latest Story

Further Information:

UMIP - Case Studies of Spin-outs
... Download PDF
(940k)

 

UPF Masterclasses:

December 1st 2009

    More information

March 31st 2009

    More information

November 25th 2008

..  More information

UPF Masterclass Hall of Fame

05/08/10

MTI Investee APATECH wins prestigious Large Deal of the Year award at 2010 Vitesse Media Awards

24/05/10

UPF increases investment in Arvia Technology

12/05/10

UPF Invests in University of Manchester med-tech spin-out, BiOxyDyn

28/04/10

UPF leads £1.15m investment round in PowerOasis

01/03/10

MTI has largest ever exit by selling investee company APATECH for $330m

22/02/10

Ai2 Limited announce appointment of new CEO

18/02/10

Nano ePrint partners with Novalia to deliver printed electronic greeting cards for Tigerprint

03/02/10

UPF leads £2m investment round to help bring new pest control products to market

23/01/10

UPF investee MYCONOSTICA launches Pneumocystis diagnostic kit in Europe and Canada

22/01/10

UPF invests £250,000 in Ai2

14/01/10

NWDA awards £9m Transitional fund to MTI

30/11/09

MTI & NWDA boosts Manchester hi-tech spin-out

13/11/09

Award winning week for the UMIP Premier Fund’s investments

26/10/09

LEIN DIAGNOSTICS secures £1 million funding from UPF and NESTA to develop pain-free medical diagnostics technology

(Download PDF 51kb)

22/10/09

UPF Invests half a million in CABLESENSE - North West hi-tech specialists back Lancaster busines

(Download PDF 30kb)

07/09/09

UPF Investee MYCONOSTICA attracts £1.7m in Series D financing to progress its fungal diagnostics

05/09/09

UPF Investee ARVIA TECHNOLOGY named in Global Cleantech 100 company listing

05/09/09

‘Proud parents’ celebrate 25th birthday of breakthrough technology

09/07/09

UPF Investee ARVIA TECHNOLOGY wins major North West Innovation award

03/07/09

Paul Strzelecki appointed Honorary Visiting Professor at The University of Manchester, (School of Electrical and Electronic Engineering)

29/06/09

UMIP scoops Business Impact Award

19/03/09

Breakthrough research by University student could speed up the recovery of injured athletes.

News from 2008>

Hi-tech investment specialists back medical coatings platform technology business

UK technology investment specialists, MTI Partners, has announced the investment of £250,000 from the UPF (the UMIP Premier Fund), in University of Manchester spin-out company, Ai2 Limited.

 

 

Ai2 is developing an innovative peptide coating technology which is able to render medical devices and implants antibacterial, thus potentially reducing the frequency of infection.


The new investment will enable the company to progress the technology platform and seek alliances and partnerships in specific applications, including contact lenses and wound dressings.


Dr. David Holbrook, Director of MTI Partners, said: “We have been watching Ai2 develop and have been impressed with its substantial technical and commercial progress for such a young organisation.”


David continues: “We have been particularly impressed with the way the company has focussed the technology on a small number of key applications, such as contact lenses, all of which represent significant unmet need markets. We look forward to helping Ai2 grow into a successful business.”


Dr. Curtis Dobson, founder and director of Ai2, said: “We are delighted to announce the successful closure of this current round. This funding will allow us to build on our successes to date and implement and validate our technology in the hands of partners. Clinical infection is a serious problem, and with this investment we can play our part in delivering a new and lasting solution.”


Chairman of Ai2, Kevin D’Silva, said: “The arrival of the UPF Fund as a substantial shareholder, and the presence of MTI Partners on the Ai2 board, will make a substantial contribution to the direction and management of the Company during 2010 and beyond. We are currently negotiating some key license applications for our peptide technology, and the target is to commence commercialisation successfully, and as soon as possible.”


The Ai2 investment comes hot on the heels of the announcement that the NWDA has awarded a MTI Partners/YFM partnership a £9 million fund management mandate to be invested in North West SMEs.

www.a-i-2.com